Skip Navigation

COVID-19 Update

We continue to monitor COVID-19 cases in our area and providers will notify you if there are scheduling changes. Please continue to call your providers with health concerns. We are providing in-person care and telemedicine appointments.

Learn about our expanded patient care options and visitor guidelines.

General Information | Self-Checker | Donate and Lend Support | Staff Appreciation | Get Email Alerts

ARVD/C Publications

Learn more about arrhythmogenic right ventricular dysplasia (arrhythmogenic right ventricular cardiomyopathy) through our selected list of published articles and books.

In This Section:

Books About ARVD/C

  • Genetics of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C), Mark M. Awad
  • Arrhythmogenic RV Cardiomyopathy/Dysplasia: Recent Advances, edited by F. I. Marcus, A Nava., G. Thiene
 

Published Resources

    • Elliott PM, Anastasakis A, Asimaki A, Basso C, Bauce B, Brooke MA, Calkins H, Corrado D, Duru F, Green KJ, Judge DP, Kelsell D, Lambiase PD, McKenna WJ, Pilichou K, Protonotarios A, Saffitz JE, Syrris P, Tandri H, Te Riele A, Thiene G, Tsatsopoulou A, van Tintelen JP. Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report. Eur J Heart Fail. 2019 Aug;21(8):955-964. doi: 10.1002/ejhf.1534. Epub 2019 Jun 18.

    • Wang W, James CA, Calkins H. Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient. Europace. 2019 Jan 1;21(1):9-21. doi: 10.1093/europace/euy063.

    • James CA, Calkins H. Arrhythmogenic Right Ventricular Cardiomyopathy: Progress Toward Personalized Management. Annu Rev Med. 2019 Jan 27;70:1-18. doi: 10.1146/annurev-med-041217-010932. Epub 2018 Oct 24.

    • Calkins H, Corrado D, Marcus F. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation. 2017 Nov 21;136(21):2068-2082. doi: 10.1161/CIRCULATIONAHA.117.030792. Review.

    • Corrado D, Link MS, Calkins H. Arrhythmogenic Right Ventricular Cardiomyopathy. N Engl J Med. 2017 Apr 13;376(15):1489-90. doi: 10.1056/NEJMc1701400. No abstract available.

    • James CA, Calkins H. Further Progress in Predicting Life-Threatening Arrhythmias in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. J Am Coll Cardiol. 2016 Dec 13;68(23):2551-2553. doi: 10.1016/j.jacc.2016.04.072. No abstract available.

    • Calkins H, Tandri H. Left Ventricular Involvement in ARVD/C: Is It Time to Readjust Our Views? Circ Arrhythm Electrophysiol. 2015 Dec;8(6):1311-2.

    • Corrado D, Wichter T, Link MS, Hauer RN, Marchlinski FE, Anastasakis A, Bauce B, Basso C, Brunckhorst C, Tsatsopoulou A, Tandri H, Paul M, Schmied C, Pelliccia A, Duru F, Protonotarios N, Estes NM 3rd, McKenna WJ, Thiene G, Marcus FI, Calkins H. Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement. Circulation. 2015 Aug 4;132(5):441-53.

    • Calkins H. Arrhythmogenic right ventricular dysplasia/cardiomyopathy - three decades of progress. Circ J. 2015;79(5):901-13.

    • Groeneweg JA, Bhonsale A, James CA, te Riele AS, Dooijes D, Tichnell C, Murray B, Wiesfeld AC, Sawant AC, Kassamali B, Atsma DE, Volders PG, de Groot NM, de Boer K, Zimmerman SL, Kamel IR, van der Heijden JF, Russell SD, Jan Cramer M, Tedford RJ, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Hauer RN, Calkins H. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet. 2015 Jun;8(3):437-46.

    • Rojas A, Calkins H. Present understanding of the relationship between exercise and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Trends Cardiovasc Med. 2015 Apr;25(3):181-188. doi: 10.1016/j.tcm.2014.10.007. Epub 2014 Oct 30. Review.

    • Tichnell C, James CA, Murray B, Tandri H, Sears SF, Calkins H. Cardiology patient page. Patient's guide to arrhythmogenic right ventricular dysplasia/cardiomyopathy: past to present. Circulation. 2014 Sep 2;130(10):e89-92.

    • Groeneweg JA, van der Zwaag PA, Olde Nordkamp LR, Bikker H, Jongbloed JD, Jongbloed R, Wiesfeld AC, Cox MG, van der Heijden JF, Atsma DE, de Boer K, Doevendans PA, Vink A, van Veen TA, Dooijes D, van den Berg MP, Wilde AA, van Tintelen JP, Hauer RN. Arrhythmogenic right ventricular dysplasia/cardiomyopathy according to revised 2010 task force criteria with inclusion of non-desmosomal phospholamban mutation carriers. Am J Cardiol. 2013 Oct 15;112(8):1197-206.

    • James CA, Calkins H. Update on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C). Curr Treat Options Cardiovasc Med. 2013 Aug;15(4):476-87.

    • Calkins H. Arrhythmogenic right ventricular dysplasia. Curr Probl Cardiol. 2013 Mar;38(3):103-23.

    • Patel HC, Calkins H. Arrhythmogenic right ventricular dysplasia. Curr Treat Options Cardiovasc Med. 2010 Dec; 12(6):598-613. View abstract.

    • Calkins H, Marcus F. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: an update. Curr Cardiol Rep. 2008 Sep;10(5):367-75. View abstract.

    • Calkins H. Arrhythmogenic right ventricular dysplasia. Trans Am Clin Climatol Assoc. 2008;119:273-86; discussion 287-8. Read full article.

    • Muthappan P, Calkins H. Arrhythmogenic right ventricular dysplasia. Prog Cardiovasc Dis. 2008 Jul-Aug;51(1):31-43. View abstract.

    • Calkins H. Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Curr Opin Cardiol. 2006 Jan; 21(1):55-63. View abstract.

    • Prakasa K, Calkins H. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Review. Curr Treat Options Cardiovasc Med., 2005 Dec;7(6):467-75 View abstract.

    • Dalal D, Nasir K, Bomma C, Prakasa K, Tandri H, Piccini J, Roguin A, Tichnell C, James C, Russell SD, Judge DP, Abraham T, Spevak PJ, Bluemke DA, Calkins H. Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation. 2005 Dec 20;112(25):3823-32. Read full article

    • Nasir K, Calkins H. Arrhythmogenic Right Ventricle Dysplasia/Cardiomyopathy. ACC Current Journal Review 2004;06.002;28-33. View abstract.

    • Marcus F, Towbin JA, Zareba W, Moss A, Calkins H, Brown M, Gear K; ARVD/C Investigators. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol. Circulation 2003 Jun 17;107(23):2975-8. Read full article.
    • Sharma A, Assis F, James CA, Murray B, Tichnell C, Tandri H, Calkins H. Misdiagnosis of ARVC leading to inappropriate ICD implant and subsequent ICD removal - lessons learned. J Cardiovasc Electrophysiol. 2019 Oct;30(10):2020-2026. doi: 10.1111/jce.14088. Epub 2019 Aug 1.

    • Te Riele AS, James CA, Groeneweg JA, Sawant AC, Kammers K, Murray B, Tichnell C, van der Heijden JF, Judge DP, Dooijes D, van Tintelen JP, Hauer RN, Calkins H, Tandri H. Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Eur Heart J. 2015 Aug 27.

    • Te Riele AS, James CA, Rastegar N, Bhonsale A, Murray B, Tichnell C, Judge DP, Bluemke DA, Zimmerman SL, Kamel IR, Calkins H, Tandri H. Yield of serial evaluation in at-risk family members of patients with ARVD/C. J Am Coll Cardiol. 2014 Jul 22;64(3):293-301.

    • Femia G, Hsu C, Singarayar S, Sy RW, Kilborn M, Parker G, McGuire M, Semsarian C, Puranik R. Impact of new task force criteria in the diagnosis of arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol. 2014 Feb 1;171(2):179-83.

    • Lindsay BD. Challenges of diagnosis and risk stratification in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Am Coll Cardiol. 2013 Nov 5;62(19):1770-1.

    • Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010 Apr;31(7):806-14. Read full article.

    • Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, Calkins H, Corrado D, Cox MG, Daubert JP, Fontaine G, Gear K, Hauer R, Nava A, Picard MH, Protonotarios N, Saffitz JE, Sanborn DM, Steinberg JS, Tandri H, Thiene G, Towbin JA, Tsatsopoulou A, Wichter T, Zareba W. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010 Apr 6;121(13):1533-41. Read full article.

    • Marcus FI, Zareba W, Calkins H, Towbin JA, Basso C, Bluemke DA, Estes NA 3rd, Picard MH, Sanborn D, Thiene G, Wichter T, Cannom D, Wilber DJ, Scheinman M, Duff H, Daubert J, Talajic M, Krahn A, Sweeney M, Garan H, Sakaguchi S, Lerman BB, Kerr C, Kron J, Steinberg JS, Sherrill D, Gear K, Brown M, Severski P, Polonsky S, McNitt S. Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm. 2009 Jul;6(7):984-92. Read full article.

    • Tandri H, Asimaki, A, Abraham T, Dalal D, Tops L, Jain R, Saffitz JE, Judge DP, Russell SD, Haluskha M, Bluemke DA, Kass DA, Calkins H. Prolonged RV endocardial activation duration: a novel marker of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2009 Jun;6(6):769-75. View abstract.

    • Asimaki A, Tandi H, Huang H, Halushka MK, Gautam S, Basso C, Thiene G, Tsatsopoulou A, Protonotarious N, McKenna WJ, Calkins H, Saffitz JE. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med. 2009 Mar 12;360(11):1075-84. Read full article.

    • Saffitz JE, Asimaki A, Huang H. Arrhythmogenic right ventricular cardiomyopathy: new insights into disease mechanisms and diagnosis. J Investig Med. 2009 Dec;57(8):861-4. Review. View abstract.

    • Bomma C, Rutberg J, Tandri H, Nasir K, Tichnell C, James C, Lima J, Bluemke D, Calkins H. Misdiagnosis of Arrhythmogenic Right Ventricular Dysplasia (ARVD). J Cardiovasc Electrophysiol 2004;15(3):300-306. View abstract.
  • Brosnan MJ, Te Riele ASJM, Bosman LP, Hoorntje ET, van den Berg MP, Hauer RNW, Flannery MD, Kalman JM, Prior DL, Tichnell C, Tandri H, Murray B, Calkins H, La Gerche A, James CA. Electrocardiographic Features Differentiating Arrhythmogenic Right Ventricular Cardiomyopathy From an Athlete's Heart. JACC Clin Electrophysiol. 2018 Dec;4(12):1613-1625. doi: 10.1016/j.jacep.2018.09.008. Epub 2018 Nov 1.

    Platonov PG, Calkins H, Hauer RN, Corrado D, Svendsen JH, Wichter T, Biernacka EK, Saguner AM, Te Riele AS, Zareba W. High interobserver variability in the assessment of epsilon waves: Implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2016 Jan;13(1):208-16. doi: 10.1016/j.hrthm.2015.08.031. Epub 2015 Aug 21.

    Calkins H. The ventricular ectopic QRS interval for diagnosis and risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Is this the answer? Heart Rhythm. 2016 Jul;13(7):1513-4. doi: 10.1016/j.hrthm.2016.04.004. Epub 2016 Apr 5. No abstract available.

    Tanawuttiwat T, Te Riele AS, Philips B, James CA, Murray B, Tichnell C, Sawant AC, Calkins H. Electroanatomic Correlates of Depolarization Abnormalities in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. J Cardiovasc Electrophysiol. 2016 Jan12.
    Platonov PG, Calkins H, Hauer RN, Corrado D, Svendsen JH, Wichter T, Biernacka EK, Saguner AM, Te Riele AS, Zareba W. High interobserver variability in the assessment of epsilon waves: Implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2016 Jan;13(1):208-16.

    Camm CF, Tichnell C, James CA, Murray B, Porterfield F, Te Riele AS, Tandri H, Calkins H. Premature ventricular contraction variability in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol. 2015 Jan;26(1):53-7.

    Huang T, James CA, Tichnell C, Murray B, Xue J, Calkins H, Tereshchenko LG. Statistical evaluation of reproducibility of automated ECG measurements: an example from arrhythmogenic right ventricular dysplasia/cardiomyopathy clinic. Biomed Signal Process Control. 2014 Sep 1;13:23-30.

    te Riele AS, James CA, Bhonsale A, Groeneweg JA, Camm CF, Murray B, Tichnell C, van der Heijden JF, Dooijes D, Judge DP, Hauer RN, Tandri H, Calkins H. Malignant arrhythmogenic right ventricular dysplasia/cardiomyopathy with a normal 12-lead electrocardiogram: a rare but underrecognized clinical entity. Heart Rhythm. 2013 Oct;10(10):1484-91. 

    Hoffmayer KS, Bhave PD, Marcus GM, James CA, Tichnell C, Chopra N, Moxey L, Krahn AD, Dixit S, Stevenson W, Calkins H, Badhwar N, Gerstenfeld EP, Scheinman MM. An electrocardiographic scoring system for distinguishing right ventricular outflow tract arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy from idiopathic ventricular tachycardia. Heart Rhythm. 2013 Apr;10(4):477-82. 

    Hoffmayer KS, Machado ON, Marcus GM, Yang Y, Johnson CJ, Ermakov S, Vittinghoff E, Pandurangi U, Calkins H, Cannom D, Gear KC, Tichnell C, Park Y, Zareba W, Marcus FI, Scheinman MM. Electrocardiographic comparison of ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract tachycardia. J Am Coll Cardiol. 2011 Aug 16;58(8):831-8. View abstract.

    Jain R, Tandri H, Daly A, Tichnell C, James C, Abraham T, Judge DP, Calkins H, Dalal D. Reader- and instrument-dependent variability in the electrocardiographic assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol. 2011 May;22(5):561-8. View abstract.

    Kamath GS, Zareba W, Delaney J, Koneru JN, McKenna W, Gear K, Polonsky S, Sherrill D, Bluemke D, Marcus F, Steinberg JS. Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2011 Feb;8(2):256-62. View abstract.

    Morin DP, Mauer AC, Gear K, Zareba W, Markowitz SM, Marcus FI, Lerman BB. Usefulness of precordial T-wave inversion to distinguish arrhythmogenic right ventricular cardiomyopathy from idiopathic ventricular tachycardia arising from the right ventricular outflow tract. Am J Cardiol. 2010 Jun 15;105(12):1821-4. View abstract.

    Jain R, Dalal D, Daly A, Tichnell C, James C, Evenson A, Jain R, Abraham T, Tan BY, Tandri H, Russell SD, Judge D, Calkins H. Electrocardiographic features of arrhythmogenic right ventricular dysplasia. Circulation. 2009 Aug 11;120(6):477-87. Read full article.

    Marcus FI, Zareba W. The electrocardiogram in right ventricular cardiomyopathy/dysplasia. How can the electrocardiogram assist in understanding the pathologic and functional changes of the heart in this disease? J Electrocardiol. 2009 Mar-Apr;42(2):136.e1-5. Epub 2009 Feb 4. Review. View abstract.

    Tandri H, Asimaki, A, Abraham T, Dalal D, Tops L, Jain R, Saffitz JE, Judge DP, Russell SD, Haluskha M, Bluemke DA, Kass DA, Calkins H. Prolonged RV endocardial activation duration: a novel marker of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2009 Jun;6(6):769-75. View abstract.

    Calkins H. Progress continues in our understanding of the electrocardiographic manifestations of arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol. 2008 Aug;19(8):782-3. Read full article.

    Piccini JP, Nasir K, Bomma C, Tandri H, Dalal D, Tichnell C, James C, Crosson J, Calkins H. Electrocardiographic Findings Over Time in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Am J Cardiol 2005 July 1;96(1):122-6. View abstract.

    Nasir K, Bomma C, Tandri H, Roguin A, Dalal D, Prakasa K, Tichnell C, James C, Spevak PJ, Marcus F, Calkins H. Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Disease Severity: A need to broaden diagnostic criteria. Circulation 2004 Sep21;110(12):1527-34. Read full article.

    Nasir K, Rutberg J, Tandri H, Berger R, Tomaselli G, Calkins H. Utility of SAECG in Arrhythmogenic right ventricular dysplasia. Ann Noninvasive Electrophysiol 2003 Apr;8(2):112-120.View abstract.
    Nasir K, Tandri H, Rutberg J, Tichnell C, Spevak P, Crosson J, Baughman KL, Kasper EK, Tomaselli GF, Berger R, Calkins H. Filtered QRS duration on SAECG predicts inducibility of ventricular tachycardia in Arrhythmogenic right ventricle dysplasia. PACE 2003;(10):1955-1960. View abstract.

    Nasir K, Bomma C, Khan F, Tandri H, Tichnell C, James C, Berger R, Calkins H. Utility of a Combined Signal-Averaged Electrocardiogram and QT Dispersion Algorithm in Identifying Arrhythmogenic Right Ventricle Dysplasia in Patients with Tachycardia of Right Ventricle Origin. Am J Cardiol 2003; 92(1):105-9. View abstract.

    • Aliyari Ghasabeh M, Te Riele ASJM, James CA, Chen HSV, Tichnell C, Murray B, Eng J, Kral BG, Tandri H, Calkins H, Kamel IR, Zimmerman SL. Epicardial Fat Distribution Assessed with Cardiac CT in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Radiology. 2018 Dec;289(3):641-648. doi: 10.1148/radiol.2018180224. Epub 2018 Aug 21.

    • Zghaib T, Ghasabeh MA, Assis FR, Chrispin J, Keramati A, Misra S, Berger R, Calkins H, Kamel I, Nazarian S, Zimmerman S, Tandri H. Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy. Circ Cardiovasc Imaging. 2018 Sep;11(9):e007546. doi: 10.1161/CIRCIMAGING.118.007546.

    • Mast TP, James CA, Calkins H, Teske AJ, Tichnell C, Murray B, Loh P, Russell SD, Velthuis BK, Judge DP, Dooijes D, Tedford RJ, van der Heijden JF, Tandri H, Hauer RN, Abraham TP, Doevendans PA, Te Riele AS, Cramer MJ. Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. JAMA Cardiol. 2017 Mar 1;2(3):293-302. doi: 10.1001/jamacardio.2016.5034.

    • Rastegar N, Te Riele AS, James CA, Bhonsale A, Murray B, Tichnell C, Calkins H, Tandri H, Bluemke DA, Kamel IR, Zimmerman SL. Fibrofatty Changes: Incidence at Cardiac MR Imaging in Patients with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Radiology. 2016 Aug;280(2):405-12. doi: 10.1148/radiol.2016150988. Epub 2016 Mar 11.

    • Vigneault DM, te Riele AS, James CA, Zimmerman SL, Selwaness M, Murray B, Tichnell C, Tee M, Noble JA, Calkins H, Tandri H, Bluemke DA. Right ventricular strain by MR quantitatively identifies regional dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy. J Magn Reson Imaging. 2016 May;43(5):1132-9. doi: 10.1002/jmri.25068. Epub 2015 Oct 26.

    • Rastegar N, Burt JR, Corona-Villalobos CP, Te Riele AS, James CA, Murray B, Calkins H, Tandri H, Bluemke DA, Zimmerman SL, Kamel IR. Cardiac MR findings and potential diagnostic pitfalls in patients evaluated for arrhythmogenic right ventricular cardiomyopathy. Radiographics. 2014 Oct;34(6):1553-70. doi: 10.1148/rg.346140194. Review.
    • Calkins H, Tandri H. Left Ventricular Involvement in ARVD/C: Is It Time to Readjust Our Views? Circ Arrhythm Electrophysiol. 2015 Dec;8(6):1311-2.

    • Te Riele AS, Marcus FI, James CA, Murray BA, Tichnell C, Zimmerman SL, Kamel IR, Crosson J, Cramer MJ, Velthuis BK, Hauer RN, Tandri H, Bluemke DA, Calkins H. The Value of Cardiac Magnetic Resonance Imaging in Evaluation of Pediatric Patients for Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. J Am Coll Cardiol. 2015 Aug 18;66(7):873-4.

    • Rastegar N, Zimmerman SL, Te Riele AS, James C, Burt JR, Bhonsale A, Murray B, Tichnell C, Judge D, Calkins H, Tandri H, Bluemke DA, Kamel IR. Spectrum of Biventricular Involvement on CMR Among Carriers of ARVD/C-Associated Mutations. JACC Cardiovasc Imaging. 2014 Nov 12.

    • Te Riele AS, James CA, Philips B, Rastegar N, Bhonsale A, Groeneweg JA, Murray B, Tichnell C, Judge DP, Van Der Heijden JF, Cramer MJ, Velthuis BK, Bluemke DA, Zimmerman SL, Kamel IR, Hauer RN, Calkins H, Tandri H. Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced. J Cardiovasc Electrophysiol. 2013 Dec;24(12):1311-20.

    • Te Riele AS, Bhonsale A, James CA, Rastegar N, Murray B, Burt JR, Tichnell C, Madhavan S, Judge DP, Bluemke DA, Zimmerman SL, Kamel IR, Calkins H, Tandri H. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol. 2013 Nov 5;62(19):1761-9.

    • Jain A, Shehata ML, Stuber M, Berkowitz SJ, Calkins H, Lima JA, Bluemke DA, Tandri H. Prevalence of left ventricular regional dysfunction in arrhythmogenic right ventricular dysplasia: a tagged MRI study. Circ Cardiovasc Imaging. 2010 May;3(3):290-7. Read full article.

    • Tops LF, Prakasa K, Tandri H, Dalal D, Jain R, Dimaano VL, Dombroski D, James C, Tichnell C, Daly A, Marcus F, Schalij MJ, Bax JJ, Bluemke D, Calkins H, Abraham TP. Prevalence and pathophysiologic attributes of ventricular dyssynchrony in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2009 Jul 28;54(5):445-51. View abstract.
    • Jain A, Tandri H, Calkins H, Bluemke DA. Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia. J Cardiovasc Magn Reson. 2008 Jun 20;10(1):32. Review. Read full article.
    • Tandri H, Macedo R, Calkins H, Marcus F, Cannom D, Scheinman M, Daubert J, Estes M 3rd, Wilber D, Talajic M, Duff H, Krahn A, Sweeney M, Garan H, Bluemke DA; Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study. Am Heart J. 2008 Jan;155(1):147-53. Epub 2007 Sep 14. Erratum in: Am Heart J. 2008 Feb;155(2):289. View abstract.
    • Indik JH, Wichter T, Gear K, Dallas WJ, Marcus FI. Quantitative assessment of angiographic right ventricular wall motion in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). J Cardiovasc Electrophysiol. 2008 Jan;19(1):39-45. Epub 2007 Spet 24. View abstract.
    • Wang J, Prakasa K, Bomma C, Tandri H, Dalal D, James C, Tichnell C, Corretti M, Bluemke D, Calkins H, Abraham TP. Comparison of novel echocardiographic parameters of right ventricular function with ejection fraction by cardiac magnetic resonance. J Am Soc Echocardiogr. 2007 Sep;20(9):1058-64. View abstract.
    • Prakasa KR, Wang J, Tandri H, Dalal D, Bomma C, Chojnowski R, James C, Tichnell C, Russell S, Judge D, Corretti M, Bluemke D, Calkins H, Abraham TP. Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Cardiol. 2007 Aug 1;100(3):507-12. Epub 2007 Jun 15. View abstract.
    • Bomma C, Dalal D, Tandri H, Prakasa K, Nasir K, Roguin A, Piccini J, Dong J, Mahadevappa M, Tichnell C, James C, Lima JA, Fishman E, Calkins H, Bluemke DA. Evolving role of multidetector computed tomography in evaluation of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Cardiol. 2007 Jul 1;100(1):99-105. Epub 2007 May 21. View abstract.
    • Macedo R, Prakasa K, Tichnell C, Marcus F, Calkins H, Lima JA, Bluemke DA. Marked lipomatous infiltration of the right ventricle: MRI findings in relation to arrhythmogenic right ventricular dysplasia. AJR Am J of Radiology. 2007 May;188(5):W423-7. View abstract.
    • Tandri H, Daya SK, Nasir K, Bomma C, Lima JA, Calkins H, Bluemke DA. Normal Reference Values for the Adult Right Ventricle by Magnetic Resonance Imaging. Am J Cardiol. 2006 Dec 15;98(12):1660-4. Epub 2006 Oct 27 View abstract.
    • Tandri H, Castillo E, Ferrari VA, Nasir K, Dalal D, Bomma C, Calkins H, Bluemke DA. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol. 2006 Dec 5;48(11):2277-84. View abstract.
    • Fritz J, Tandri H, Rodriquez R, Calkins H, Bluemke D. Evaluation and course of an unusual case of arrhythmogenic right ventricular dysplasia. Case Report, The Intl J Cardiovasc Imag June 2006 Vol. 22:269-273. View abstract.
    • Prakasa KR, Dalal D, Wang J, Bomma C, Tandri H, Dong J, James C, Tichnell C, Russell SD, Spevak P, Corretti M, Bluemke DA, Calkins H, Abraham TP. Feasibility and variability of three dimensional echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Cardiol. 2006 Mar 1;97(5):703-9. Epub 2006 Jan 13. View abstract.
    • Fritz J, Soliayappan M, Tandri H, Bomma C, Gence A, Joao JAC, Bluemke DA. Right Ventricle Shape and Contraction Patterns and Relationship to MRI Findings. J Comput Assist Tomogr 2005 November/December;29(6):725-733. View abstract.
    • Bomma C, Dalal D, Tandri H, Prakasa K, Nasir K, Roguin A, Tichnell C, James C, Lima JAC, Calkins H, Bluemke DA. Regional Differences in Systolic & Diastolic Function in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) using Magnetic Resonance Imaging. Am J Cardiol 2005 June 15;95(12):1507-11. View abstract.
    • Roguin A, Donahue JK, Bomma CS, Bluemke DA, Halperin HR. Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator. Pacing Clin Electrophysiol. 2005 Apr;28(4):336-8. View abstract.
    • Yoerger DM, Marcus F, Sherrill D, Calkins H, Towbin JA, Zareba W, Picard MH; Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia. J Am Coll Cardiol. 2005 Mar 15;45(6):860-5. View abstract.
    • Tandri H et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol. 2005 Jan 4 ;45(1):98-103. View abstract.
    • Castillo E, Tandri H, Rodriguez ER, Nasir K, Rutberg J, Calkins H, Lima JA, Bluemke DA. Arrhythmogenic right ventricular dysplasia: ex vivo and in vivo fat detection with black-blood MR imaging. Radiology. 2004 Jul;232(1):38-48.
    • Tandri H, Bomma C, Calkins H, Bluemke DA. Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia. J Magn Reson Imaging. 2004 Jun; 19(6):848-58. Review. View abstract.
    • Tandri H, Friedrich MG, Calkins H, Bluemke DA. MRI of arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Magn Reson. 2004; 6(2):557-63.View abstract.
    • Tandri H et al. Magnetic resonance imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol. 2003 May;14(5):476-82. View abstract.
    • Bluemke DA, et al. MR Imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. Cardiology. 2003;99(3):153-62. View abstract.
    • Tandri H, Calkins H, Marcus FI. Controversial role of magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular dysplasia. Am J Cardiol 2003 Sept;92:(5)649. View abstract.
    • Tandri H, Rutberg J, Bluemke D, Calkins H. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol 2002; 13(11):1180. View abstract.
    • Orgeron GM, Bhonsale A, Migliore F, James CA, Tichnell C, Murray B, Bertaglia E, Cadrin-Tourigny J, De Franceschi P, Crosson J, Tandri H, Corrado D, Calkins H. Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience. J Am Heart Assoc. 2018 Nov 6;7(21):e008782. doi: 10.1161/JAHA.118.008782.

    • Orgeron GM, Te Riele A, Tichnell C, Wang W, Murray B, Bhonsale A, Judge DP, Kamel IR, Zimmerman SL, Tandri H, Calkins H, James CA. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Circ Arrhythm Electrophysiol. 2018 Feb;11(2):e005593. doi: 10.1161/CIRCEP.117.005593. Epub 2018 Feb 16.
    • Schinkel AF. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Circ Arrhythm Electrophysiol. 2013 Jun;6(3):562-8. 

    • James CA, Tichnell C, Murray B, Daly A, Sears SF, Calkins H. General and Disease-Specific Psychosocial Adjustment in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients with Implantable Cardioverter Defibrillators: A Large Cohort Study. Circ Cardiovasc Genet. 2012 Jan 11. Read full article.
      ​​​​​​​
    • Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Caoll Cardiol. 2011 Sep 27:58(14):1485-96. View abstract.
    • Bilchick KC, Judge DP, Calkins H, Marine JE. Use of a coronary sinus lead and biventricular ICD to correct a sensing abnormality in a patient with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol. 2006 Mar;17(3):317-20. View abstract.
    • Piccini JP, Dalal D, Roguin A, Bomma C, Cheng A, Prakasa K, Dong J, Tichnell C, James C, Russell S, Crosson J, Berger RD, Marine JE, Tomaselli G, Calkins H. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm. 2005 Nov;2(11):1188-94. View abstract.
    • Roguin A, Bomma CS, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, Crosson J, Spevak PJ, Berger RD, Halperin HR, Calkins H. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2004 May 19;43(10):1843-52. View abstract.
    • Roguin A, Zviman M, Meininger G, Rodríguez R, Dickfeld T, Bluemke D, Lardo A, Berger R, Calkins H, Halperin H. Modern Pacemaker and Implantable Cardioverter-Defibrillator Systems can be MRI safe: In-vitro and In-vivo assessment of safety and function at 1.5-Tesla. Circulation 2004;110(5):475-482. View abstract.
    • Roguin A, Bomma C, Nasir K, Tandri H, Tichnell C, James C, Rutberg J, Crosson J, Spevak J, Berger R, Halperin H, Calkins H. Implantable Cardioverter-Defibrillators in Patients with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. J Am Coll Cardiol 2004;43(10):1843-52. View abstract.
    •  Calkins H. Antiarrhythmic drug therapy in patients with arrhythmogenic dysplasia/cardiomyopathy: Is there a role for flecainide? Heart Rhythm. 2017 Apr;14(4):570-571. doi: 10.1016/j.hrthm.2017.01.016. Epub 2017 Jan 12. No abstract available.
    • Corrado D, Wichter T, Link MS, Hauer RN, Marchlinski FE, Anastasakis A, Bauce B, Basso C, Brunckhorst C, Tsatsopoulou A, Tandri H, Paul M, Schmied C, Pelliccia A, Duru F, Protonotarios N, Estes NM 3rd, McKenna WJ, Thiene G, Marcus FI, Calkins H. Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement. Circulation. 2015 Aug 4;132(5):441-53.

    • Ermakov S, Hoffmayer KS, Gerstenfeld EP, Scheinman MM. Combination drug therapy for patients with intractable ventricular tachycardia associated with right ventricular cardiomyopathy. Pacing Clin Electrophysiol. 2014 Jan;37(1):90-4. doi: 10.1111/pace.12250. Epub 2013 Sep 17.

    • Marcus GM, Glidden DV, Polonsky B, Zareba W, Smith LM, Cannom DS, Estes NA 3rd, Marcus F, Scheinman MM; Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. J Am Coll Cardiol. 2009 Aug 11;54(7):609-15. Read full article.
    •  Assis FR, Krishnan A, Zhou X, James CA, Murray B, Tichnell C, Berger R, Calkins H, Tandri H, Mandal K. Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2019 Jul;16(7):1003-1010. doi: 10.1016/j.hrthm.2019.01.019. Epub 2019 Jan 21.
      ​​​​​​​
    • Philips B, Te Riele AS, Sawant A, Kareddy V, James CA, Murray B, Tichnell C, Kassamali B, Nazarian S, Judge DP, Calkins H, Tandri H. Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2015 Apr;12(4):716-25.
    • Philips B, Madhavan S, James C, Tichnell C, Murray B, Needleman M, Bhonsale A, Nazarian S, Laurita KR, Calkins H, Tandri H. High prevalence of catecholamine-facilitated focal ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol. 2013 Feb;6(1):160-6. 

    • Philips B, Madhavan S, James C, Tichnell C, Murray B, Dalal D, Bhonsale A, Nazarian S, Judge DP, Russell SD, Abraham T, Calkins H, Tandri H. Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Arrhythm Electrophysiol. 2012 Jun 1;5(3):499-505.

    • Berruezo A, Fernández-Armenta J, Mont L, Zeljko H, Andreu D, Herczku C, Boussy T, Tolosana JM, Arbelo E, Brugada J.Circ Arrhythm Electrophysiol. Combined endocardial and epicardial catheter ablation in arrhythmogenic right ventricular dysplasia incorporating scar dechanneling technique. 2012 Feb 1;5(1):111-21. Epub 2011 Dec 28. View abstract.
    • Della Bella P, Brugada J, Zeppenfeld K, Merino J, Neuzil P, Maury P, Maccabelli G, Vergara P, Baratto F, Berruezo A, Wijnmaalen AP. Epicardial ablation for ventricular tachycardia: a European multicenter study. Circ Arrhythm Electrophysiol. 2011 Oct;4(5):653-9. Epub 2011 Aug 13. View abstract.
    • Arruda M, Armaganijan L, Fahmy T, Di Biase L, Patel D, Natale A. Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia. J Interv Card Electrophysiol. 2009 Aug;25(2):129-33. Epub 2008 Oct 31. View abstract.
    • Dalal D, Jain R, Tandri H, Dong J, Eid SM, Prakasa K, Tichnell C, James, C, Abraham T, Russell SD, Sinha S, Judge DP, Bluemke DA, Marine JE, Calkins H. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2007 Jul 31;50(5):432-40. Epub 2007 Jul 16 View abstract.
    • Ruwald AC, Marcus F, Estes NA 3rd, Link M, McNitt S, Polonsky B, Calkins H, Towbin JA, Moss AJ, Zareba W. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2015 Jul 14;36(27):1735-43. doi: 10.1093/eurheartj/ehv110. Epub 2015 Apr 20.

    • Sawant AC, Te Riele AS, Tichnell C, Murray B, Bhonsale A, Tandri H, Judge DP, Calkins H, James CA. Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers. Heart Rhythm. 2016 Jan;13(1):199-207.

    • Sawant AC, Calkins H. Relationship between arrhythmogenic right ventricular dysplasia and exercise. Card Electrophysiol Clin. 2015 Jun;7(2):195-206.
      ​​​​​​​
    • Sawant AC, Calkins H. Sports in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and desmosomal mutations. Herz. 2015 May; 40(3):402-9.
    • Judge DP and Chelko SP. Further Evidence of Harm from Exercise in ARVD/C. JACC 2015; 65(14): 1451-3.

    • Rojas A, Calkins H. Present understanding of the relationship between exercise and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Trends Cardiovasc Med. 2015 Apr;25(3):181-188. doi: 10.1016/j.tcm.2014.10.007. Epub 2014 Oct 30. Review.

    • Sawant AC, Bhonsale A, te Riele AS, Tichnell C, Murray B, Russell SD, Tandri H, Tedford RJ, Judge DP, Calkins H, James CA. Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations. J Am Heart Assoc. 2014 Dec;3(6):e001471.
    • Fabritz L, Fortmueller L, Vloumidi E, Sakhtivel S, Syeda F, Leube R, Kirchhof P, Krusche C. 11 arrhythmogenic right ventricular cardiomyopathy-like phenotype induced by endurance training and prevented by preload reduction in heterozygeous desmoglein-2 mutants. Heart. 2014 Jan;100 Suppl 1:A5. 

    •  Perrin MJ, Angaran P, Laksman Z, Zhang H, Porepa LF, Rutberg J, James C, Krahn AD, Judge DP, Calkins H, Gollob MH. Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2013 Nov 5;62(19):1772-9. 

    • James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H, Tedford RJ, Judge DP, Calkins H. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol. 2013 Oct 1;62(14):1290-7. 

    • Zorzi A, ElMaghawry M, Rigato I, Cardoso Bianchini F, Crespi Ponta G, Michieli P, Migliore F, Perazzolo Marra M, Bauce B, Basso C, Schiavon M, Thiene G, Iliceto S, Corrado D. Exercise-induced normalization of right precordial negative T waves in arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 2013 Aug 1;112(3):411-5. 

    • Pelliccia A, Corrado D, Bjornstad HH, Panhuyzen-Goedkoop N, Urhausen A, Carre F, Anastasakis A, Vanhees L, Arbustini E, Priori S. Recommendations for participation in competitive sport and leisure-time physical activity in individauls with cardiomyopathies, myocarditis and pericarditis. Eur J Cardiovasc Prev Rehabil. 2006 Dec; 13(6):876-85. View abstract.
    • Kirchhof P, Fabritz L, Zwiener M, Witt H, Schafers M, Zellerhoff S, Paul M, Athai T, Hiller KH, Baba HA, Breithardt G, Ruiz P, Wichter T, Levkau B. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation. 2006 Oct 24; 114 (17):1799-806. Read full article.
    • Maron BJ, Chaitman BR, Ackerman MJ, Bayes de Luna A, Corrado D, Crosson JE, Deal BJ, Driscoll DJ, Estes NA 3rd, Araujo CG, Liang DH, Mitten MJ, Myerburg RJ, Pelliccia A, Thompson PD, Towbin JA, Van Camp SP; Working Groups of the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention; Councils on Clinical Cardiology and Cardiovascular Disease in the Young. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004 Jun 8;109(22):2807-16. Read full article.
    •  James CA, Calkins H, Jing L, Raghunath S, Hartzel DN, Leader JB, Kirchner HL, Smelser DT, Carey DJ, Kelly MA, Sturm AC, Alsaid A, Fornwalt BK, Haggerty CM. Prevalence and Electronic Health Record-based Phenotype of Loss-of-function Genetic Variants in Arrhythmogenic Right Ventricular Cardiomyopathy-associated Genes. Circ Genom Precis Med. 2019 Oct 22. doi: 10.1161/CIRCGEN.119.002579. [Epub ahead of print]

    • van Lint FHM, Murray B, Tichnell C, Zwart R, Amat N, Lekanne Deprez RH, Dittmann S, Stallmeyer B, Calkins H, van der Smagt JJ, van den Wijngaard A, Dooijes D, van der Zwaag PA, Schulze-Bahr E, Judge DP, Jongbloed JDH, van Tintelen JP, James CA. Circ  Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De Novo. Genom Precis Med. 2019 Aug;12(8):e002467. doi: 10.1161/CIRCGEN.119.002467. Epub 2019 Aug 6.

    • Hoorntje ET, Posafalvi A, Syrris P, van der Velde KJ, Bolling MC, Protonotarios A, Boven LG, Amat-Codina N, Groeneweg JA, Wilde AA, Sobreira N, Calkins H, Hauer RNW, Jonkman MF, McKenna WJ, Elliott PM, Sinke RJ, van den Berg MP, Chelko SP, James CA, van Tintelen JP, Judge DP, Jongbloed JDH. No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy. PLoS One. 2018 Aug 30;13(8):e0203078. doi: 10.1371/journal.pone.0203078. eCollection 2018.

    • Haggerty CM, Murray B, Tichnell C, Judge DP, Tandri H, Schwartz M, Sturm AC, Matsumura ME, Murray MF, Calkins H, Fornwalt BK, James CA. Managing Secondary Genomic Findings Associated With Arrhythmogenic Right Ventricular Cardiomyopathy: Case Studies and Proposal for Clinical Surveillance.  Circ Genom Precis Med. 2018 Jul;11(7):e002237. doi: 10.1161/CIRCGEN.118.002237. No abstract available.

    • Murray B, Hoorntje ET, Te Riele ASJM, Tichnell C, van der Heijden JF, Tandri H, van den Berg MP, Jongbloed JDH, Wilde AAM, Hauer RNW, Calkins H, Judge DP, James CA, van Tintelen JP, Dooijes D. Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC).  J Cardiovasc Electrophysiol. 2018 Jul;29(7):1004-1009. doi: 10.1111/jce.13621. Epub 2018 May 21.
      ​​​​​​​
    • Haggerty CM, James CA, Calkins H, Tichnell C, Leader JB, Hartzel DN, Nevius CD, Pendergrass SA, Person TN, Schwartz M, Ritchie MD, Carey DJ, Ledbetter DH, Williams MS, Dewey FE, Lopez A, Penn J, Overton JD, Reid JG, Lebo M, Mason-Suares H, Austin-Tse C, Rehm HL, Delisle BP, Makowski DJ, Mehra VC, Murray MF, Fornwalt BK. Electronic health record phenotype in subjects with genetic variants associated with arrhythmogenic right ventricular cardiomyopathy: a study of 30,716 subjects with exome sequencing. Genet Med. 2017 Nov;19(11):1245-1252. doi: 10.1038/gim.2017.40. Epub 2017 May 4.
    • Te Riele AS, James CA, Murray B, Tichnell C, Amat-Alarcon N, Burks K, Tandri H, Calkins H. Polydefkis M, Judge DP. Absence of a Primary Role for SCN10A Mutations in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. J Cardiovasc Transl Res. 2016 Jan 5.

    • Groeneweg JA, Bhonsale A, James CA, Te Riele AS, Dooijes D, Tichnell C, Murray B, Wiesfeld AC, Sawant AC, Kassamali B, Atsma DE, Volders PG, de Groot NM, de Boer K, Zimmerman SL, Kamel IR, van der Heijden JF, Russell SD, Cramer MJ, Tedford RJ, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Hauer RN, Calkins H. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia    /Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet. 2015 Mar 27.

    • Bhonsale A, Groeneweg JA, James CA, Dooijes D, Tichnell C, Jongbloed JD, Murray B, Te Riele AS, van den Berg MP, Bikker H, Atsma DE, de Groot NM, Houweling AC, van der Heijden JF, Russell SD, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Calkins H, Hauer RN. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. Eur Heart J. 2015 Jan 23.

    • Te Rijdt WP, Jongbloed JD, de Boer RA, Thiene G, Basso C, van den Berg MP, van Tintelen JP. Clinical utility gene card for: arrhythmogenic right ventricular cardiomyopathy (ARVC). Eur J Hum Genet. 2014 Feb;22(2). No abstract available.

    • Lodder EM, Bezzina CR. Arrhythmogenic right ventricular cardiomyopathy: growing evidence for complex inheritance. Circ Cardiovasc Genet. 2013 Dec;6(6):525-7. 

    • Baskin B, Skinner JR, Sanatani S, Terespolsky D, Krahn AD, Ray PN, Scherer SW, Hamilton RM. TMEM43 mutations associated with arrhythmogenic right ventricular cardiomyopathy in non-Newfoundland populations. Hum Genet. 2013 Nov;132(11):1245-52. 

    • Valtuille L, Paterson I, Kim DH, Mullen J, Sergi C, Oudit GY. A case of lamin A/C mutation cardiomyopathy with overlap features of ARVC: a critical role of genetic testing. Int J Cardiol. 2013 Oct 9;168(4):4325-7. 

    • Bhonsale A, James CA, Tichnell C, Murray B, Madhavan S, Philips B, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H. Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. Circ Arrhythm Electrophysiol. 2013 Jun;6(3):569-78. 

    • Murray B, Wagle R, Amat-Alarcon N, Wilkens A, Stephens P, Zackai EH, Goldmuntz E, Calkins H, Deardorff MA, Judge DP. A family with a complex clinical presentation characterized by arrhythmogenic right ventricular dysplasia/cardiomyopathy and features of branchio-oculo-facial syndrome. Am J Med Genet A. 2013 Feb;161A(2):371-6. 

    • van der Zwaag PA, van Rijsingen IA, Asimaki A, Jongbloed JD, van Veldhuisen DJ, Wiesfeld AC, Cox MG, van Lochem LT, de Boer RA, Hofstra RM, Christiaans I, van Spaendonck-Zwarts KY, Lekanne dit Deprez RH, Judge DP, Calkins H, Suurmeijer AJ, Hauer RN, Saffitz JE, Wilde AA, van den Berg MP, van Tintelen JP. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail. 2012 Nov;14(11):1199-207. 

    • Kapplinger JD, Landstrom AP, Salisbury BA, Callis TE, Pollevick GD, Tester DJ, Cox MG, Bhuiyan Z, Bikker H, Wiesfeld AC, Hauer RN, van Tintelen JP, Jongbloed JD, Calkins H, Judge DP, Wilde AA, Ackerman MJ. Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. J Am Coll Cardiol. 2011 Jun 7;57(23):2317-27. View abstract.
    • Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H, McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, Wolpert C, Zipes DP. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011 Aug;8(8):1308-39. View abstract.
    • Tan BY, Jain R, den Haan AD, Chen Y, Dalal D, Tandri H, Amat-Alarcon N, Daly A, Tichnell C, James C, Calkins H, Judge DP. Shared desmosome gene findings in early and late onset arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Transl Res. 2010 Dec;3(6):663-73. Read full article.
    • Xu T. Yang Z, Vatta M, Rampazzo A, Beffagna G, Pilichou K, Scherer SE, Saffitz J, Kravitz J, Zareba W, Danieli GA, Lorenzon A, Nava A, Bauce B, Thiene G, Basso C, Calkins H, Gear K, Marcus F, Towbin JA; Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2010 Feb 9;55(6):587-97. Read full article.
    • den Haan AD, Tan BY, Zikusoka MN, Llado LI, Jain R, Daly A, Tichnell C, James C, Amat-Alarcon N, Abraham T, Russell SD, Bluemke DA, Calkins H, Dalal D, Judge DP. Comprehensive desmosome mutation analysis in north Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Cardiovasc Genet. 2009 Oct;2(5):428-35. Read full article.
    • Dalal D, Tandri H, Judge DP, Amat N, Macedo R, Jain R, Tichnell C, Daly A, James C, Russell SD, Abraham T, Bluemke DA, Calkins H. Morphologic variants of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy a genetics-magnetic resonance imaging correlation study. J Am Coll Cardiol. 2009; 53(15): 1289-99. View abstract.
    • Hershberger RE, Lindenfeld J, Mestroni L, Seidman CE, Taylor MR, Towbin JA. Genetic evaluation of cardiomyopathy—a Heart Failure Society of America practice guideline. J Card Fail. 2009 Mar:15(2):83-97. View abstract.
    • Judge DP and Johnson NM. Genetic Evaluation of Familial Cardiomyopathy. Journal of Cardiovascular Translational Research, 2008; DOI 10.1007/s12265-008-902501. View abstract.
    • Awad MM, Calkins H, Judge DP. Mechanisms of Disease: Molecular Genetics of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Nature Clin Pract Cardiovasc Med. 2008 Apr 1:1-10. View abstract.
    • Dalal D, James C, Devanagondi R, Tichnell C, Tucker A, Prakasa K, Spevak P, Bluemke D, Abraham T, Russell S, Calkins H, Judge D. Penetrance of Mutations in Plakophilin-2 among Families with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. J Am Coll Cardiol. 2006 Oct 3:48(7):1416-24. Epub 2006 Sep 12. View abstract.
    • Awad MM, Dalal D, Tichnell C, James C, Tucker A, Abraham T, Spevak PJ, Calkins H, Judge DP. Recessive Arrhythmogenic Right Ventricular Dysplasia due to Novel Cryptic Splice Mutation in PKP2. Hum Mutat. 2006 Nov;27(11):1157. Read full article.
    • Awad MM, Dalal D, Cho E, Alarcon NA, James C, Tichnell C, Tucker A, Russell SD, Bluemke DA, Dietz HC, Calkins H, Judge DP. DSG2 mutations contribute to Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. Am J Hum Genet. 2006 Jul;79(1):136-42. Epub 2006 Apr 28. Read full article.
    • Dalal D, Molin L, Piccini J, Tichnell C, James C, Bomma C, Prakasa K, Towbin J, Marcus F, Spevak P, Bluemke D, Abraham T, Russell S, Calkins H, Judge D. Clinical Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated with Mutations in Plakophilin-2. Circulation 2006 Apr 4;113(13):1641-9. Read full article.
    • Yang Z, Bowles NE, Scherer SE, Taylor MD, Kearney DL, Ge S, Nadvoretskiy VV, DeFreitas G, Carabello B, Brandon LI, Godsel LM, Green KJ, Saffitz JE, Li H, Danieli GA, Calkins H, Marcus F, Towbin JA. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res. 2006 Sep 15;99(6):646-55. Epub 2006 Aug 17. Read full article.
    • Te Riele AS, Agullo-Pascual E, James CA, Leo-Macias A, Cerrone M, Zhang M, Lin X, Lin B, Sobreira NL, Amat-Alarcon N, Marsman RF, Murray B, Tichnell C, van der Heijden JF, Dooijes D, van Veen TA, Tandri H, Fowler SJ, Hauer RN, Tomaselli G, van den Berg MP, Taylor MR, Brun F, Sinagra G, Wilde AA, Mestroni L, Bezzina CR, Calkins H, Peter van Tintelen J, Bu L, Delmar M, Judge DP. Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.  Cardiovasc Res. 2017 Jan;113(1):102-111. doi: 10.1093/cvr/cvw234. Erratum in: Cardiovasc Res. 2017 May 1;113(6):691.

    • Asimaki A, Protonotarios A, James CA, Chelko SP, Tichnell C, Murray B, Tsatsopoulou A, Anastasakis A, te Riele A, Kléber AG, Judge DP, Calkins H, Saffitz JE. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells. Circ Arrhythm Electrophysiol. 2016 Feb;9(2):e003688. doi: 10.1161/CIRCEP.115.003688.

    • Asimaki A, Kapoor S, Plovie E, Karin Arndt A, Adams E, Liu Z, James CA, Judge DP, Calkins H, Churko J, Wu JC, MacRae CA, Kléber AG, Saffitz JE. Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy. Sci Transl Med 2014; 6(240):240ra74.
    • Karakikes I, Termglinchan V, Wu JC. Human-induced pluripotent stem cell models of inherited cardiomyopathies. Curr Opin Cardiol. 2014 Feb 26. 

    • Cerrone M, Lin X, Zhang M, Agullo-Pascual E, Pfenniger A, Chkourko-Gusky H, Novelli V, Kim C, Tirasawadichai T, Judge DP, Rothenberg E, Chen HS, Napolitano C, Priori S, Delmar M. Missense Mutations in Plakophilin-2 Cause Sodium Current Deficit and Associate with a Brugada Syndrome Phenotype. Circulation. 2013 Dec 18. 

    • Kim C, Wong J, Wen J, Wang S, Wang C, Spiering S, Kan NG, Forcales S, Puri PL, Leone TC, Marine JE, Calkins H, Kelly DP, Judge DP, Chen HS. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs. Nature. 2013 Feb 7;494(7435):105-10. 

    • Hong TT, Cogswell R, James CA, Kang G, Pullinger CR, Malloy MJ, Kane JP, Wojciak J, Calkins H, Scheinman MM, Tseng ZH, Ganz P, De Marco T, Judge DP, Shaw RM. Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2012 Jan 31. [Epub ahead of print] View abstract.
      ​​​​​​​
    • Asimaki A, Tandri H, Duffy ER, Winterfield JR, Mackey-Bojack S, Picken MM, Cooper LT, Wilber DJ, Marcus FI, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, Stevenson WG, McKenna WJ, Gautam S, Remick DG, Calkins H, Saffitz JE. Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2011 Oct;4(5):743-52. Epub 2011 Aug 22. View abstract.
    • Tandri H, Asimaki A, Dalal D, Saffitz JE, Halushka MK, Calkins H. Gap Junction Remodeling in a Case of Arrhythmogenic Right Ventricular Dysplasia Due to a Plakophilin-2 Mutation. J. Cardiovasc Electrophysiol. 2008 Jun 12. Read full article.
    •  Gupta R, Tichnell C, Murray B, Rizzo S, Te Riele A, Tandri H, Judge DP, Thiene G, Basso C, Calkins H, James CA. Comparison of Features of Fatal Versus Nonfatal Cardiac Arrest in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.  Am J Cardiol. 2017 Jul 1;120(1):111-117. doi: 10.1016/j.amjcard.2017.03.251. Epub 2017 Apr 13.
    • Katritsis G, Shah AS, James CA, Murray B, Tichnell C, Judge DP, Calkins H, Tedford RJ. Surgical Correction of Tricuspid Regurgitation in Patients with ARVD/C. Heart Rhythm Case Rep. 2015 Sep 1;1(5):326-330.

    • Mufti HN, Rajda M, Legare JF. Arrhythmogenic right ventricular cardiomyopathy: use of a left ventricular assist device as a bridge to transplantation? J Artif Organs. 2013 Dec;16(4):498-500. 

    • Valchanov K, Goddard M, Ghosh S. Anesthesia for Heart Transplantation in Patients With Arrhythmogenic Right Ventricular Dysplasia: A Case Series. J Cardiothorac Vasc Anesth. 2013 Aug 29. 

    • Tedford RJ, James C, Judge DP, Tichnell C, Murray B, Bhonsale A, Philips B, Abraham T, Dalal D, Halushka MK, Tandri H, Calkins H, Russell SD. Cardiac transplantation in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2012 Jan 17;59(3):289-90. Read full article.
    • Asimaki A, Saffitz JE. The role of endomyocardial biopsy in ARVC: looking beyond histology in search of new diagnostic markers. J Cardiovasc Electrophysiol. 2011 Jan;22(1):111-7. View abstract.
    • Yoda M, Minami K, Fritzsche D, Tendrich G, Schulte-Eistrup S, Koerfer R. Three cases of orthotopic heart transplantation for arrhythmogenic right ventricular cardiomyopathy. Ann Thorac Surg. 2005 Dec;80(6):2358-60. View abstract.
    • Yamaji K, Fujimoto S, Ikeda Y, Masuda K, Nakamura S, Saito Y, Yutani C. Apoptotic myocardial cell death in the setting of arrhythmogenic right ventricular cardiomyopathy. Acta Cardiol. 2005 Oct;60(5):465-70. View abstract.
    • Basso C, Thiene G. Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? Cardiovasc Pathol. 2005 Jan-Feb;14(1):37-41. Review. View abstract.
    • Chimenti C, Pieroni M, Maseri A, Frustaci A. Histologic findings in patients with clinical and instrumental diagnosis of sporadic arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol. 2004 Jun 16; 43(12): 2305-13. View abstract.
    •  Te Riele ASJM, James CA, Sawant AC, Bhonsale A, Groeneweg JA, Mast TP, Murray B, Tichnell C, Dooijes D, van Tintelen JP, Judge DP, van der Heijden JF, Crosson J, Hauer RNW, Calkins H, Tandri H. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Pediatric Population: Clinical Characterization and Comparison With Adult-Onset Disease. JACC Clin Electrophysiol. 2015 Dec;1(6):551-560. doi: 10.1016/j.jacep.2015.08.004. Epub 2015 Oct 22.
    • Saprungruang A, Tumkosit M, Kongphatthanayothin A. The presence of epsilon waves in all precordial leads (V1 -V6 ) in a 13-year-old boy with arrhythmogenic right ventricular dysplasia (ARVD). Ann Noninvasive Electrocardiol. 2013 Sep;18(5):484-6. 

    • Yoo SJ, Grosse-Wortmann L, Hamilton RM. Magnetic resonance imaging assessment of arrhythmogenic right ventricular cardiomyopathy/dysplasia in children. Korean Circ J. 2010 Aug;40(8):357-67. Read full article.
    • Sequeira IB, Kirsh JA, Hamilton RM, Russell JL, Gross GJ. Utility of exercise testing in children and teenagers with arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 2009 Aug 1;104(3):411-3. View abstract.
    • Sanatani S, Duncan W, Chan S. The challenge of diagnosing arrhythmogenic right ventricular cardiomyopathy in the young. Pediatr Cardiol. 2008 Jul;29(4):800-3. Epub 2008 Apr 22. View abstract.
    • Hodes AR, Tichnell C, Te Riele AS, Murray B, Groeneweg JA, Sawant AC, Russell SD, van Spaendonck-Zwarts KY, van den Berg MP, Wilde AA, Tandri H, Judge DP, Hauer RN, Calkins H, van Tintelen JP, James CA. Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy. Heart. 2015 Dec 30.

    • Marcus FI, Edson S, Towbin JA. Reply: Pregnancy in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2013 Nov 12;62(20):1911. 

    • Murray B, Tichnell C, James C, Tandri H, Calkins H. Pregnancy in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol. 2013 Nov 12;62(20):1910-1.  

    • Stec S, Krynski T, Baran J, Kulakowski P. "Rescue" ablation of electrical storm in arrhythmogenic right ventricular cardiomyopathy in pregnancy. BMC Cardiovasc Disord. 2013 Aug 13;13:58. 

    • Lee LC, Bathgate SL, Macri CJ. Arrhythmogenic right ventricular dysplasia in pregnancy: a case report. J Reprod Med. 2006 Sep;51(9):725-8. View abstract.
    • Bauce B, Daliento L, Frigo G, Russo G, Nava A. Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Obstet Gynecol Reprod Biol. 2006 Aug;127(2):186-9. Epub 2005 Dec 7. View abstract.
    • Doyle NM, Monga M, Montgomery B, Dougherty AH. Arrhythmogenic right ventricular cardiomyopathy with implantable cardioverter defibrillator placement in pregnancy. J Matern Fetal Neonatal Med. 2005 Aug;18(2):141-4. View abstract.
    • Rustico MA, Benettoni A, Fontaliran F, Fontaine G. Prenatal echocardiographic appearance of arrhythmogenic right ventricle dysplasia: a case report. Fetal Diagn Ther. 2001 Nov-Dec;16(6):433-6. View article.
    • Philips B, Madhavan S, James CA, Te Riele AS, Murray B, Tichnell C, Bhonsale A, Nazarian S, Judge DP, Calkins H, Tandri H, Cheng A. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Cardiac Sarcoidosis: Distinguishing Features When the Diagnosis is Unclear. Circ Arrhythm Electrophysiol. 2014 Mar 1. 

    • Tanawuttiwat T, Sager SJ, Hare JM, Myerburg RJ. Myocarditis and ARVC/D: variants or mimics? Heart Rhythm. 2013 Oct;10(10):1544-8. Epub 2013 Jun 14. No abstract available.

    • Wlodarska EK, Wozniak O, Konka M, Piotrowska-Kownacka D, Walczak E, Hoffman P. Isolated ventricular noncompaction mimicking arrhythmogenic right ventricular cardiomyopathy--a study of nine patients. Int J Cardiol. 2010 Nov 5;145(1):107-11. View abstract.
    • Roberts JD, Veinot JP, Rutberg J, Gollob MH. Inherited cardiomyopathies mimicking arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Pathol. 2010 Sep-Oct;19(5):316-20. View abstract.
    • Bauce B, Frigo G, Benini G, Michieli P, Basso C, Folino AF, Rigato I, Mazzotti E, Daliento L, Thiene G, Nava A. Differences and similarities between arrhythmogenic right ventricular cardiomyopathy and athlete's heart adaptations. Br J Sports Med. 2010 Feb;44(2):148-54. View abstract.
    • Vasaiwala SC, Finn C, Delpriore J, Leya F, Gaggermeier J, Akar JG, Santucci P, Dajani K, Bova D, Picken MM, Basso C, Marcus F, Wilber DJ. Prospective Study of Cardiac Sarcoid Mimicking Arrhythmogenic Right Ventricular Dysplasia. J Cardiovasc Electrophysiol. 2008 Nov 11. View abstract.
    • Tandri H, Bomma C, Calkins H. Unusual Presentation of Cardiac Sarcoidosis. Congest Heart Fail. 2007 Mar-Apr;13(2):116-8. View abstract.
    • Tandri H, Ferrari VA, Bomma C, Khurram N, Bluemke D, Lima J, Calkins H. Findings on Magnetic Resonance Imaging of Idiopathic Right Ventricular Outflow Tachycardia: Is There Evidence for Structural Heart Disease? Am J Cardiol 2004;94(11):1441-5. View abstract.
    • O’Donnell D, et al. Clinical and electrophysiology differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur Heart J. 2003 May;24(9):801-10. View abstract.
    • Cadrin-Tourigny J, Bosman LP, Nozza A, Wang W, Tadros R, Bhonsale A, Bourfiss M, Fortier A, Lie ØH, Saguner AM, Svensson A, Andorin A, Tichnell C, Murray B, Zeppenfeld K, van den Berg MP, Asselbergs FW, Wilde AAM, Krahn AD, Talajic M, Rivard L, Chelko S, Zimmerman SL, Kamel IR, Crosson JE, Judge DP, Yap SC, van der Heijden JF, Tandri H, Jongbloed JDH, Guertin MC, van Tintelen JP, Platonov PG, Duru F, Haugaa KH, Khairy P, Hauer RNW, Calkins H, Te Riele ASJM, James CA. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2019 Jun 14;40(23):1850-1858. doi: 10.1093/eurheartj/ehz103.
      ​​​​​​​
    • Zghaib T, Bourfiss M, van der Heijden JF, Loh P, Hauer RN, Tandri H, Calkins H, Nazarian S, Te Riele ASJM, Zimmerman SL, Velthuis BK. Atrial Dysfunction in Arrhythmogenic Right Ventricular Cardiomyopathy. Circ Cardiovasc Imaging. 2018 Sep;11(9):e007344. doi: 10.1161/CIRCIMAGING.117.007344

    • Wang W, Cadrin-Tourigny J, Bhonsale A, Tichnell C, Murray B, Monfredi O, Chrispin J, Crosson J, Tandri H, James CA, Calkins H. Arrhythmic outcome of arrhythmogenic right ventricular cardiomyopathy patients without implantable defibrillators. J Cardiovasc Electrophysiol. 2018 Oct;29(10):1396-1402. doi: 10.1111/jce.13668. Epub 2018 Jun 27.

    • Bosman LP, Sammani A, James CA, Cadrin-Tourigny J, Calkins H, van Tintelen JP, Hauer RNW, Asselbergs FW, Te Riele ASJM. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis. Heart Rhythm. 2018 Jul;15(7):1097-1107. doi: 10.1016/j.hrthm.2018.01.031. Epub 2018 Feb 3.

    • Assis FR, Camm CF, Te Riele ASJM, James CA, Murray B, Tichnell C, Chrispin J, Misra S, Calkins H, Tandri H. Nocturnal Premature Ventricular Contraction Burden as a Marker of Disease Severity in Arrhythmogenic Right Ventricular Cardiomyopathy. JACC Clin Electrophysiol. 2017 Dec 26;3(13):1607-1608. doi: 10.1016/j.jacep.2017.08.018. Epub 2017 Nov 6. No abstract available.

    • Calkins H, Corrado D, Marcus F. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation. 2017 Nov 21;136(21):2068-2082. doi: 10.1161/CIRCULATIONAHA.117.030792. Review.

    • Gilotra NA, Bhonsale A, James CA, Te Riele ASJ, Murray B, Tichnell C, Sawant A, Ong CS, Judge DP, Russell SD, Calkins H, Tedford RJ. Heart Failure Is Common and Under-Recognized in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. Circ Heart Fail. 2017 Sep;10(9). pii: e003819. doi: 10.1161/CIRCHEARTFAILURE.116.003819.

    • Rhodes AC, Murray B, Tichnell C, James CA, Calkins H, Sears SF. Quality of life metrics in arrhythmogenic right ventricular cardiomyopathy patients: The impact of age, shock and sex. Int J Cardiol. 2017 Dec 1;248:216-220. doi: 10.1016/j.ijcard.2017.08.026. Epub 2017 Aug 14.

    • Bhonsale A, Te Riele ASJM, Sawant AC, Groeneweg JA, James CA, Murray B, Tichnell C, Mast TP, van der Pols MJ, Cramer MJM, Dooijes D, van der Heijden JF, Tandri H, van Tintelen JP, Judge DP, Hauer RNW, Calkins H. Cardiac phenotype and long-term prognosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia patients with late presentation. Heart Rhythm. 2017 Jun;14(6):883-891. doi: 10.1016/j.hrthm.2017.02.013. Epub 2017 Feb 12.

    • Choudhary N, Tompkins C, Polonsky B, McNitt S, Calkins H, Mark Estes NA 3rd, Krahn AD, Link MS, Marcus FI, Towbin JA, Zareba W. Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry. J Cardiovasc Electrophysiol. 2016 May;27(5):555-62. doi: 10.1111/jce.12947. Epub 2016 Mar 21.

    • Calkins H. Evidence Mounts That Severity of Disease Impacts the Prognosis for Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.  JACC Clin Electrophysiol. 2016 Feb;2(1):116-117. doi: 10.1016/j.jacep.2015.12.007. Epub 2016 Jan 5. No abstract available.
    • Te Riele AS, James CA, Groeneweg JA, Sawant AC, Kammers K, Murray B, Tichnell C, van der Heijden JF, Judge DP, Dooijes D, van Tintelen JP, Hauer RN, Calkins H, Tandri H. Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Eur Heart J. 2015 Aug 27.

    • Groeneweg JA, Bhonsale A, James CA, Te Riele AS, Dooijes D, Tichnell C, Murray B, Wiesfeld AC, Sawant AC, Kassamali B, Atsma DE, Volders PG, de Groot NM, de Boer K, Zimmerman SL, Kamel IR, van der Heijden JF, Russell SD, Cramer MJ, Tedford RJ, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Hauer RN, Calkins H. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia     /Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet. 2015 Mar 27.

    • Calkins H, Tandri H. High-dose isoproterenol testing for diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy: is there a role? Circ Arrhythm Electrophysiol. 2014 Aug;7(4):565-6.

    • Te Riele AS, James CA, Rastegar N, Bhonsale A, Murray B, Tichnell C, Judge DP, Bluemke DA, Zimmerman SL, Kamel IR, Calkins H, Tandri H. Yield of serial evaluation in at-risk family members of patients with ARVD/C. J Am Coll Cardiol. 2014 Jul 22;64(3):293-301.
    • Bao J, Wang J, Yao Y, Wang Y, Fan X, Sun K, He DS, Marcus FI, Zhang S, Hui R, Song L. Correlation of ventricular arrhythmias with genotype in arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet. 2013 Dec;6(6):552-6. 

    • Calkins H. Hot and humid: a bad combination for you, me, and patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2013 Dec;10(12):1867-8. 

    • Zorzi A, Migliore F, Elmaghawry M, Silvano M, Marra MP, Niero A, Nguyen K, Rigato I, Bauce B, Basso C, Thiene G, Iliceto S, Corrado D. Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification. J Cardiovasc Electrophysiol. 2013 Dec;24(12):1321-7. 

    • te Riele AS, Bhonsale A, James CA, Rastegar N, Murray B, Burt JR, Tichnell C, Madhavan S, Judge DP, Bluemke DA, Zimmerman SL, Kamel IR, Calkins H, Tandri H. Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol. 2013 Nov 5;62(19):1761-9. 

    • Lindsay BD. Challenges of diagnosis and risk stratification in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Am Coll Cardiol. 2013 Nov 5;62(19):1770-1.

    • Camm CF, James CA, Tichnell C, Murray B, Bhonsale A, te Riele AS, Judge DP, Tandri H, Calkins H. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Heart Rhythm. 2013 Nov;10(11):1661-8. 

    • Deac M, Alpendurada F, Fanaie F, Vimal R, Carpenter JP, Dawson A, Miller C, Roussin I, di Pietro E, Ismail TF, Roughton M, Wong J, Dawson D, Till JA, Sheppard MN, Mohiaddin RH, Kilner PJ, Pennell DJ, Prasad SK. Prognostic value of cardiovascular magnetic resonance in patients with suspected arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol. 2013 Oct 9;168(4):3514-21. 

    • Bhonsale A, James CA, Tichnell C, Murray B, Madhavan S, Philips B, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H. Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. Circ Arrhythm Electrophysiol. 2013 Jun;6(3):569-78.

    • Hong TT, Cogswell R, James CA, Kang G, Pullinger CR, Malloy MJ, Kane JP, Wojciak J, Calkins H, Scheinman MM, Tseng ZH, Ganz P, De Marco T, Judge DP, Shaw RM. Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2012 Jun;9(6):961-7. Free PMC Article

 
back to top button